| Combined Therapeutics Inc Wins $250,000 MilliporeSigma Advance Biotech Grant | Editors | 09/25/20 | National |
| Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor | Sarah de Crescenzo | 08/17/20 | Boston |
| GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod | Sarah de Crescenzo | 08/06/20 | National |
| IgGenix Grabs $10M to Advance Antibody Treatments for Allergies | Sarah de Crescenzo | 08/05/20 | San Francisco |
| Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort | Sarah de Crescenzo | 07/29/20 | San Diego |
| Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists | Sarah de Crescenzo | 07/27/20 | San Diego |
| After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test | Sarah de Crescenzo | 07/14/20 | San Diego |
| VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs | Sarah de Crescenzo | 07/09/20 | San Diego |
| Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases | Sarah de Crescenzo | 07/01/20 | Boston |
| Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs | Sarah de Crescenzo | 06/25/20 | Boston |
| Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs | Sarah de Crescenzo | 06/18/20 | San Diego |
| Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer | Sarah de Crescenzo | 06/17/20 | San Diego |
| Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA | Sarah de Crescenzo | 06/11/20 | Texas |
| Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs | Sarah de Crescenzo | 06/05/20 | Boston |
| Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More | Sarah de Crescenzo | 05/29/20 | National |
| At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs | Sarah de Crescenzo | 04/28/20 | Boston |
| Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal | Sarah de Crescenzo | 04/08/20 | San Francisco |
| VenBio Partners Bags $394M to Back More Medicine-Making Biotechs | Sarah de Crescenzo | 04/03/20 | Boston |
| Flagship Adds $1.1B for New Meds, More AI, & “Health Security” | Sarah de Crescenzo | 04/02/20 | National |
| Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic | Sarah de Crescenzo | 04/01/20 | San Diego |
| With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund | Dan Stanton | 03/11/20 | Europe |
| Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug | Sarah de Crescenzo | 03/11/20 | Seattle |
| Culture Biosciences Adds $15M for New Software, Bioreactor Expansion | Gareth Macdonald | 03/05/20 | San Francisco |
| Biogen, Sangamo Ink Neuro Deal for New “Gene Regulation” Therapies | Sarah de Crescenzo | 02/28/20 | National |
| EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device | Sarah de Crescenzo | 02/19/20 | Boston |
| CEOs of Women’s Health Companies Fight to Open Investment Floodgates | Sarah de Crescenzo | 01/22/20 | San Diego |
| UK Startups Double in Number Backed By Larger Scale Investments: Report | Melissa Fassbender | 01/09/20 | Europe |
| Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis | Sarah de Crescenzo | 01/09/20 | San Diego |
| Novo Holdings Repositions Antibiotics Funding Amid “Deteriorated” Market | Melissa Fassbender | 01/07/20 | Europe |
| China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development | Melissa Fassbender | 01/06/20 | National |
